Clinical Trials Directory

Trials / Terminated

TerminatedNCT00525434

Evaluation of Safety and Efficacy of Using Seraffix LTB - System for Excisional Biopsy Wounds Closure

Evaluation of Safety and Efficacy of Using Seraffix LTB - (Laser Tissue Bonding) System for Excisional Biopsy Wounds Closure

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Seraffix · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and effectiveness of using Seraffix LTB system for excisional biopsy wounds closure

Detailed description

Excisional biopsy of the skin is a biopsy in which an entire lesion is removed. An excisional biopsy is in contrast to an incisional biopsy in which only a sample of tissue is cut into and removed. It is most frequently done to diagnose a skin growth such as a mole, or cancer of the skin. The most common method of wound closure of skin excisions is interrupted nonabsorbable sutures. The sutures should be removed as soon as adequate intrinsic bonding strength is sufficient, depending mostly on the specific body region (from 5-7 days for the face and up to 12-14 days for trunk and extremities). Laser energy, also known as laser welding, has been used on limited basis as an alternative to traditional wound closure method. There have been two fundamental approaches to laser assisted bonding of tissues: 1. Laser welding-heating the approximated edges of cuts in tissues by a laser beam; 2. Laser soldering- applying a biological solder onto the approximated edges and heating the solder (and the underlying tissue). Seraffix has developed the Seraffix LTB (Laser Tissue Bonding) System - a laser system for soft tissue bonding. This innovative system includes features that make laser soldering suitable for clinical use. The Seraffix system is composed of CO2 laser device, propriety grip device (Clamps) and soldering agent (Human Albumin).

Conditions

Interventions

TypeNameDescription
DEVICESeraffix LTBwounds closure by using laser and albumin

Timeline

Start date
2008-11-01
Primary completion
2009-07-01
Completion
2009-11-01
First posted
2007-09-05
Last updated
2011-06-09

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00525434. Inclusion in this directory is not an endorsement.